Oragenics Inc.
OGEN
Last
$0.46
Day
-1.5%
1y
-66.7%
5y
-100.0%
52w
-68.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0627d
EMA 21
0.49
EMA 50
0.51
EMA 200
1.20
20d high
-12.6%
5y high
-100.0%
5y range
0th
Positions held
Your positionsOGEN isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-33
Hold
avoid
Signal
Strong Sell
Target
$0.52
Stop
$0.42
Stop distance
7.9%
Target vs last
+14.0%
Fundamentals
| Market cap | $2.09M | Enterprise value | -$1.78M | Trailing P/E | — | Forward P/E | -0.04 |
| PEG | -8.96 | Price / book | 0.57 | Beta | 1.26 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -13.1% | ROA | -1.7% | Debt / equity | — |
| Current ratio | 3.02 | Free cash flow | -$6.68M | Analyst recommendation | none | Mean target | — |
| 52w high | $1.45 | 52w low | $0.46 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — | — |
| Net income | — | -$2.2M | -$2.3M | -$3.1M | -$2.3M | -$2.2M |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | -$2.3M | -$2.5M | -$3.1M | -$1.7M | -$2.0M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$9.8M | -$10.6M | -$20.7M | -$14.3M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$9.4M | -$10.6M | -$20.9M | -$14.4M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsOGEN · daily-11.0% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin